Alterity Therapeutics (NASDAQ:ATHE) traded sharply lower on Friday after the Australian biotech announced plans to raise A$3.25M (USD2.13M) in gross proceeds via a placement of its ordinary shares to ...
Source LinkAlterity Therapeutics (NASDAQ:ATHE) traded sharply lower on Friday after the Australian biotech announced plans to raise A$3.25M (USD2.13M) in gross proceeds via a placement of its ordinary shares to ...
Source Link
Comments